Targeted deletion of cannabinoid receptors CB1 and CB 2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Δ9-tetrahydrocannabinol

Journal of Leukocyte Biology

Volumn 83, Issue 3, 2008, Pages 785-796

  Buchweitz, John P ^a,b   Karmaus, Peer W F ^b   Williams, Kurt J ^b   Harkema, Jack R ^b   Kaminski, Norbert E ^a,b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Inflammation; Influenza; Lung; Mice

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; DRONABINOL; GAMMA INTERFERON; VIRUS HEMAGGLUTININ; VIRUS HEMAGGLUTININ 1; RNA; TETRAHYDROCANNABINOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BLOOD VESSEL PERMEABILITY; CD4+ T LYMPHOCYTE; CELL DENSITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; GOBLET CELL; INFLAMMATION; INFLUENZA; INFLUENZA VIRUS A; LUNG INFECTION; LUNG LAVAGE; MOUSE; MUCOUS CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROVOCATION TEST; VIRUS LOAD; VIRUS STRAIN; ANIMAL; ARTICLE; C57BL MOUSE; DISEASE MODEL; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; PATHOPHYSIOLOGY; T LYMPHOCYTE;

MUS; ORTHOMYXOVIRIDAE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; INFLAMMATION; INFLUENZA A VIRUS; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RNA; T-LYMPHOCYTES; TETRAHYDROCANNABINOL;

EID: 43349095841     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0907618     Document Type: Conference Paper

References (40)

1. Klein, T. W., Cabral, G. A. (2006) Cannaboinoid-induced immune suppression and modulation of antigen-presenting cells. J. Neuroimmune Pharmacol. 1, 50-64.
2. Morahan, P. S., Klykken, P. C., Smith, S. H., Harris, L. S., Munson, A. E. (1979) Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect. Immun. 23, 670-674.
3. Fischer-Stenger, K., Updegrove, A. W., Cabral, G. A. (1992) Δ 9-Tetrahydrocannabinol decreases cytotoxic T lymphocyte activity to herpes simplex virus type 1-infected cells. Proc. Soc. Exp. Biol. Med. 200, 422-430.
4. Klein, T. W., Newton, C., Friedman, H. (1994) Resistance to Legionella pneumophila suppressed by the marijuana component, tetrahydrocannabinol. J. Infect. Dis. 169, 1177-1179.
5. Buchweitz, J. P., Karmaus, P. W., Harkema, J. R., Williams, K. J., Kaminski, N. E. (2007) Modulation of airway responses to influenza A/PR/8/34 by {Δ}9-tetrahydrocannabinol in C57BL/6 mice. J. Pharmacol. Exp. Ther. 323, 675-683.
6. Lu, T., Newton, C., Perkins, I., Friedman, H., Klein, T. W. (2006) Role of cannabinoid receptors in Δ-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila. Eur. J. Pharmacol. 532, 170-177.
7. Klein, T. W., Newton, C. A., Nakachi, N., Friedman, H. (2000) Δ 9-Tetrahydrocannabinol treatment suppresses immunity and early IFN-γ, IL-12, and IL-12 receptor β 2 responses to Legionella pneumophila infection. J. Immunol. 164, 6461-6466.
8. Jan, T. R., Farraj, A. K., Harkema, J. R., Kaminski, N. E. (2003) Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice. Toxicol. Appl. Pharmacol. 188, 24-35.
9. Kawakami, Y., Klein, T. W., Newton, C., Djeu, J. Y., Specter, S., Friedman, H. (1988) Suppression by Δ-9-tetrahydrocannabinol of interleukin 2-induced lymphocyte proliferation and lymphokine-activated killer cell activity. Int. J. Immunopharmacol. 10, 485-488.
10. Ouyang, Y., Hwang, S. G., Han, S. H., Kaminski, N. E. (1998) Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Mol. Pharmacol. 53, 676-683.
11. Yea, S. S., Yang, K. H., Kaminski, N. E. (2000) Role of nuclear factor of activated T-cells and activator protein-1 in the inhibition of interleukin-2 gene transcription by cannabinol in EL4 T-cells. J. Pharmacol. Exp. Ther. 292, 597-605.
12. Ronni, T., Sareneva, T., Pirhonen, J., Julkunen, I. (1995) Activation of IFN-α, IFN-γ, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J. Immunol. 154, 2764-2774.
13. Bot, A., Reichlin, A., Isobe, H., Bot, S., Schulman, J., Yokoyama, W. M., Bona, C. A. (1996) Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice. J. Virol. 70, 5668-5672.
14. Pettit, D. A., Anders, D. L., Harrison, M. P., Cabral, G. A. (1996) Cannabinoid receptor expression in immune cells. Adv. Exp. Med. Biol. 402, 119-129.
15. Schatz, A. R., Lee, M., Condie, R. B., Pulaski, J. T., Kaminski, N. E. (1997) Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol. 142, 278-287.
16. McCoy, K. L., Matveyeva, M., Carlisle, S. J., Cabral, G. A. (1999) Cannabinoid inhibition of the processing of intact lysozyme by macrophages: evidence for CB2 receptor participation. J. Pharmacol. Exp. Ther. 289, 1620-1625.
17. Buckley, N. E., McCoy, K. L., Mezey, E., Bonner, T., Zimmer, A., Felder, C. C., Glass, M., Zimmer, A. (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol. 396, 141-149.
18. Zhu, L. X., Sharma, S., Stolina, M., Gardner, B., Roth, M. D., Tashkin, D. P., Dubinett, S. M. (2000) Δ-9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J. Immunol. 165, 373-380.
19. Kaplan, B. L., Rockwell, C. E., Kaminski, N. E. (2003) Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes. J. Pharmacol. Exp. Ther. 306, 1077-1085.
20. Kaplan, B. L., Ouyang, Y., Rockwell, C. E., Rao, G. K., Kaminski, N. E. (2005) 2-Arachidonoyl-glycerol suppresses interferon-γ production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2. J. Leukoc. Biol. 77, 966-974.
21. Costa, B., Colleoni, M., Conti, S., Parolaro, D., Franke, C., Trovato, A. E., Giagnoni, G. (2004) Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw. Naunyn Schmiedebergs Arch. Pharmacol. 369, 294-299.
22. Watzl, B., Scuderi, P., Watson, R. R. (1991) Influence of marijuana components (THC and CBD) on human mononuclear cell cytokine secretion in vitro. Adv. Exp. Med. Biol. 288, 63-70.
23. Srivastava, M. D., Srivastava, B. I., Brouhard, B. (1998) Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology 40, 179-185.
24. Karsak, M., Gaffal, E., Date, R., Wang-Eckhardt, L., Rehnelt, J., Petrosino, S., Starowicz, K., Steuder, R., Schlicker, E., Cravatt, B., Mechoulam, R., Buettner, R., Werner, S., Di Marzo, V., Tuting, T., Zimmer, A. (2007) Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316, 1494-1497.
25. Plopper, C. G., Mariassy, A. T., Lollini, L. O. (1983) Structure as revealed by airway dissection. A comparison of mammalian lungs. Am. Rev. Respir. Dis. 128, S4-S7.
26. Topham, D. J., Tripp, R. A., Doherty, P. C. (1997) CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol. 159, 5197-5200.
27. Buchweitz, J. P., Harkema, J. R., Kaminski, N. E. (2007) Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicol. Pathol. 35, 424-435.
28. Newton, C. A., Lu, T., Nazian, S. J., Perkins, I., Friedman, H., Klein, T. W. (2004) The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2. J. Leukoc. Biol. 76, 854-861.
29. Azorlosa, J. L., Heishman, S. J., Stitzer, M. L., Mahaffey, J. M. (1992) Marijuana smoking: effect of varying Δ 9-tetrahydrocannabinol content and number of puffs. J. Pharmacol. Exp. Ther. 261, 114-122.
30. Coopman, K., Smith, L. D., Wright, K. L., Ward, S. G. (2007) Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis. Int. Immunopharmacol. 7, 360-371.
31. Ghosh, S., Preet, A., Groopman, J. E., Ganju, R. K. (2006) Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes. Mol. Immunol. 43, 2169-2179.
32. Nilsson, O., Fowler, C. J., Jacobsson, S. O. (2006) The cannabinoid agonist WIN 55,212-2 inhibits TNF-α-induced neutrophil transmigration across ECV304 cells. Eur. J. Pharmacol. 547, 165-173.
33. Smith, S. R., Denhardt, G., Terminelli, C. (2001) The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models. Eur. J. Pharmacol. 432, 107-119.
34. Lavon, I., Sheinin, T., Meilin, S., Biton, E., Weksler, A., Efroni, G., Bar-Joseph, A., Fink, G., Avraham, A. (2003) A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation. Mol. Pharmacol. 64, 1334-1341.
35. Molina-Holgado, F., Molina-Holgado, E., Guaza, C. (1998) The endogenous cannabinoid anandamide potentiates interleukin-6 production by astrocytes infected with Theiler's murine encephalomyelitis virus by a receptor-mediated pathway. FEBS Lett. 433, 139-142.
36. Sacerdote, P., Martucci, C., Vaccani, A., Bariselli, F., Panerai, A. E., Colombo, A., Parolaro, D., Massi, P. (2005) The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. J. Neuroimmunol. 159, 97-105.
37. Newton, C. A., Klein, T. W., Friedman, H. (1994) Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by Δ-9-tetrahydrocannabinol injection. Infect. Immun. 62, 4015-4020.
38. Yuan, M., Kiertscher, S. M., Cheng, Q., Zoumalan, R., Tashkin, D. P., Roth, M. D. (2002) Δ 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J. Neuroimmunol. 133, 124-131.
39. Takizawa, T., Tatematsu, C., Ohashi, K., Nakanishi, Y. (1999) Recruitment of apoptotic cysteine proteases (caspases) in influenza virus-induced cell death. Microbiol. Immunol. 43, 245-252.
40. Wurzer, W. J., Planz, O., Ehrhardt, C., Giner, M., Silberzahn, T., Pleschka, S., Ludwig, S. (2003) Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J. 22, 2717-2728.